Fernando Vargas Madueno

Statistics

Publications

Citations

H-Index

Active since

2013

Affiliations

Fernando Vargas Madueno is an author at Moffitt Cancer Center specializing in relapsed diffuse large b-cell lymphoma, cd19-directed bispecific antibodies, and chimeric antigen receptor t cell combination therapy.

Publications per year

2013–2024

Publications

Glofitamab in Combination with Rituximab Plus Ifosfamide, Carboplatin, and Etoposide Shows Favorable Efficacy and Manageable Safety in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Eligible for Stem Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: Results from a Phase Ib Study

Catherine Diefenbach, Paolo F. Caimi, Nakhle S. Saba et al. · Blood · 2024 · 13 citations

Medicine, Hematology, Oncology +17

Concomitant typhlitis and <i>Clostridium difficile</i> colitis developed after first R-CHOP chemotherapy in a non-Hodgkin lymphoma patient

Parichart Junpaparp, Saranya Buppajarntham, Fernando Vargas Madueno et al. · BMJ Case Reports · 2013 · 10 citations

Medicine, Infectious Diseases, Oncology +17

1–2 of 2